High blood pressure has no symptoms until it causes one of them — a stroke, a heart attack, kidney damage. That is precisely why it is called the silent condition, and it is why London runs two separate, complementary screening routes rather than relying on one. Understanding how the NHS Health Check and the community pharmacy blood pressure service fit together explains a lot about how population-scale hypertension screening actually functions across the capital, and where the gaps still sit.
Two different screening programmes, one goal
The NHS Health Check is a national prevention programme, not a one-off test. It is offered to adults aged 40 to 74 in England, once every five years, and it is aimed specifically at people who do not already have a diagnosed condition such as heart disease, chronic kidney disease, diabetes, hypertension, or a history of stroke — those individuals are expected to be under regular review by their existing care team instead. Local councils carry a statutory responsibility to offer the check to everyone eligible in their area, which is what makes it a genuinely population-level programme rather than something patients have to seek out themselves.
Running alongside it, and covering different ground, is the NHS Community Pharmacy Blood Pressure Check service — formally the Hypertension Case-Finding Advanced Service — which has operated since October 2021. Where the Health Check is a scheduled, five-yearly, multi-measure assessment, the pharmacy service is opportunistic and narrowly focused: a free blood pressure reading, available to consenting adults aged 40 and over who have not been diagnosed with hypertension and have not had a professional reading taken in the past six months. Pharmacists can also check people under 40 at their discretion. The two programmes were not designed to compete; they were designed to close each other’s gaps.
What the NHS Health Check actually covers
A Health Check appointment, usually delivered by a nurse or healthcare assistant at a GP surgery (occasionally by a pharmacist or via the local council), is built around cardiovascular risk. In addition to a blood pressure measurement, it typically includes a cholesterol blood test, height and weight measurement to calculate BMI, a discussion of lifestyle and family history, and often a blood sugar test to assess diabetes risk. The combined purpose is to spot early warning signs across five conditions at once: stroke, chronic kidney disease, heart disease, type 2 diabetes, and dementia. That breadth is the programme’s strength — and also why it can only be offered every five years rather than continuously.
The pharmacy route: catching hypertension between appointments
The community pharmacy service exists precisely to cover that gap between five-year cycles. Because it requires no appointment and no referral, a reading can happen while someone is collecting a repeat prescription. The pathway that follows is graded by result: a normal reading comes with brief advice on maintaining healthy behaviours; a high reading triggers an offer of Ambulatory Blood Pressure Monitoring, a 24-hour reading taken from the pharmacy, to confirm whether the elevation is sustained; a very high reading results in urgent same-day referral to a GP within 24 hours. Every reading, whatever the result, is sent back to the patient’s own GP practice so it becomes part of their permanent record rather than a one-off data point that disappears. Non-registered pharmacy staff can take the readings, but the responsible pharmacist remains accountable for what happens with the result.
How delivery varies across London’s boroughs
Because the Health Check is commissioned locally rather than run centrally, delivery is not uniform across the capital’s 32 boroughs, and that variation is worth understanding rather than glossing over. Newham, for example, commissions its borough’s GP federation to deliver the checks directly, folding them into existing primary care capacity rather than running a separate service. Hounslow has been recorded as a strong performer against both national and London-wide averages for uptake. And a digital version of the Health Check — letting eligible residents complete parts of the assessment without a face-to-face appointment — began piloting in early 2025 in a small number of local authorities, Lambeth among them. None of this is exotic; it is the ordinary reality of a statutory programme delivered through 32 separate commissioning relationships, each shaped by local primary care capacity and each accountable for its own uptake figures.
| Feature | NHS Health Check | Pharmacy Blood Pressure Check |
|---|---|---|
| Who it’s for | Adults 40–74 without existing cardiovascular, kidney or diabetes diagnoses | Adults 40+ without a hypertension diagnosis, or under 40 at pharmacist discretion |
| Frequency | Once every five years | Opportunistic, whenever a reading is due or requested |
| What’s measured | Blood pressure, cholesterol, BMI, blood sugar, lifestyle review | Blood pressure only, with escalation to 24-hour monitoring if needed |
| Where delivered | GP surgery, sometimes pharmacy or local council setting | Community pharmacy, no appointment required |
| What happens next | Risk discussion and referral if a condition is flagged | Graded response: advice, ABPM, or urgent GP referral within 24 hours |
Why the two-track model matters for the capital
Neither programme alone would catch hypertension at population scale. A five-yearly check misses anyone whose blood pressure rises in year two; a pharmacy-only model misses anyone who never happens to walk into a participating pharmacy. Together, they form a wider net — one scheduled and comprehensive, the other continuous and narrow — and both funnel their findings back into the same GP record. For a city with London’s population density and borough-by-borough variation in primary care capacity, that redundancy is not inefficiency; it is the design. Early detection only works for the capital if there is more than one way to be found, and understanding how these two routes fit together is the first step to seeing why hypertension screening at scale is a system, not a single test.